0001214659-20-000639.txt : 20200128
0001214659-20-000639.hdr.sgml : 20200128
20200128163018
ACCESSION NUMBER: 0001214659-20-000639
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200124
FILED AS OF DATE: 20200128
DATE AS OF CHANGE: 20200128
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brister Mark
CENTRAL INDEX KEY: 0001323223
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37897
FILM NUMBER: 20554713
MAIL ADDRESS:
STREET 1: C/O DEXCOM, INC.
STREET 2: 5555 OBERLIN DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OBALON THERAPEUTICS INC
CENTRAL INDEX KEY: 0001427570
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5421 AVENIDA ENCINAS
STREET 2: SUITE F
CITY: San Diego
STATE: CA
ZIP: 92008
BUSINESS PHONE: 858-480-2400
MAIL ADDRESS:
STREET 1: 5421 AVENIDA ENCINAS
STREET 2: SUITE F
CITY: San Diego
STATE: CA
ZIP: 92008
4
1
marketforms-47574.xml
PRIMARY DOCUMENT
X0306
4
2020-01-24
0001427570
OBALON THERAPEUTICS INC
OBLN
0001323223
Brister Mark
C/O OBALON THERAPEUTICS, INC.
5421 AVENIDA ENCINAS, SUITE F
CARLSBAD
CA
92008
false
true
false
false
Chief Technology Officer
Restricted Stock Units
2020-01-24
4
A
false
110281
0
A
Common Stock
110281
110281
D
Each restricted stock unit represents a right to receive one share of the Issuer's common stock, the cash equivalent thereof, or a combination of both, based on the achievement of stock price goals over a three-year performance period ending December 31, 2022.
/s/ Nooshin Hussainy as attorney-in-fact for Mark Brister
2020-01-28